Intuitive Surgical, Inc.: Beat — EPS $3.00, Revenue $3.05B
Earnings BeatQ3 2026 · After-market
@trystockwhiz
Did Intuitive Surgical, Inc. (ISRG) beat earnings today?
Yes, Intuitive Surgical, Inc. (ISRG) beat Wall Street analyst expectations for Q3 2026, reporting higher-than-expected EPS and higher-than-expected revenue.
Earnings Per Share+13.64% surprise
$3.00Actual
Expected: $2.64
vs. year ago +25.0%
Total Revenue+4.87% surprise
$3.05BActual
Expected: $2.91B
vs. year ago +21.7%
Released Oct 20 · 4:05 PM ET
Earning Report
| Metric | Q3 2026 | Q3 2025 | YoY Change % |
|---|---|---|---|
| Revenue | $3.05B | $2.51B | +21.7% |
| Revenue detail — reported lines | |||
| └─Instruments and accessories | $1.80B | $1.52B | +18.3% |
| └─Systems | $769.10M | $590.40M | +30.3% |
| Consolidated revenue by source | |||
| └─Services | $482.20M | $395.90M | +21.8% |
| Net Income | $522.80M | $704.40M | -25.8% |
| GAAP Basic EPS | $1.50 | $1.98 | -24.2% |
| GAAP Diluted EPS | $1.49 | $1.95 | -23.1% |
| Non-GAAP Net Income | $1.05B | $867.20M | +21.6% |
| Non-GAAP Diluted EPS | $3.00 | $2.40 | +25.0% |
Financial Outlook / Guidance
| Metric | Next Quarter Outlook | 2026 Financial Outlook |
|---|---|---|
| Worldwide da Vinci procedure growth | — | approximately 14% to 15% |
| Non-GAAP gross profit margin | — | 68.7% to 69.3% (tariffs 0.9% of revenue) |
| Non-GAAP operating expense growth | — | 11% to 13% |
Business Highlights
- ➤Worldwide da Vinci and Ion procedures grew approximately 15%.
- ➤Placed 546 da Vinci systems, including 315 da Vinci 5 systems.
- ➤Placed 56 Ion endoluminal systems during the quarter.
- ➤da Vinci installed base reached 12,094 systems at September 30, 2026.
- ➤Ion installed base reached 1,152 systems at September 30, 2026.
- ➤Repurchased 7.8 million shares of common stock during the quarter.
- ➤Reached written agreement to settle the da Vinci antitrust litigation, subject to Court approval.
- ➤Completed acquisition of da Vinci and Ion distribution businesses in Italy, Spain, and Portugal.
Management Commentary
Dave Rosa, Intuitive CEO
“Our strong performance this quarter was marked by broad-based adoption across our multi-port, single-port, and Ion platforms, with customers using our systems to perform, on average, over 10,000 procedures per day throughout the period. Looking ahead, we will remain focused on serving customers across geographies and sites of care, enabling them to deliver better patient care, outcomes, and experiences, reduce the total cost of care, and expand access to minimally invasive care.”